92.5 A+
Gonadorelin
Also known as: GnRH, Factrel, Lutrepulse
FDA Approved Unregulated — Sold as research chemical
Research Evidence 90.0/100
Safety Profile 95.0/100
61 Clinical Trials
Unknown: 6 PHASE4: 7 PHASE3: 17 PHASE2, PHASE3: 3 PHASE2: 14 PHASE1, PHASE2: 1 NA: 13
- MEDAM (Menopur Retrospective Data prograM) Unknown Phase COMPLETED Ferring Pharmaceuticals
- CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION Unknown Phase UNKNOWN Azienda Ospedaliero-Universitaria Careggi
- Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome Unknown Phase UNKNOWN Ain Shams Maternity Hospital
- A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation Unknown Phase COMPLETED Merck KGaA, Darmstadt, Germany
- TSH And AMH in Infertile Women Unknown Phase UNKNOWN Ain Shams Maternity Hospital
Showing 5 of 61 trials.
20 Research Papers
- Nationwide Survey of Institutional Factors Related to the Use of Gonadotropin-Releasing Hormone Analogs for Ovarian Protection in Women Receiving Chemotherapy in Japan. J Obstet Gynaecol Res unknown
- Protocol flexibility in PCOS: a combination of controlled ovarian stimulation and endometrial preparation strategies shows no impact on live birth outcomes after frozen embryo transfer-a retrospective cohort study. Gynecol Endocrinol unknown
- Effect of GnRH administration on egg production, hormonal and biochemical profile and ovarian histomorphology of spent naked neck layers. Poult Sci unknown
- THE GONADOTROPIN RELEASING HORMONE AGONIST, DESLORELIN ACETATE, IS CONTRAINDICATED FOR MITIGATION OF AGGRESSION AND REPRODUCTIVE BEHAVIOR IN MALE COWNOSE RAYS (RHINOPTERA BONASUS). J Zoo Wildl Med unknown
- An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol. J Ovarian Res unknown
Showing 5 of 20 papers by citation count.
FDA Data
Not FDA-Approved
Gonadorelin has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is Gonadorelin FDA approved?
No, Gonadorelin has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has Gonadorelin been studied in?
Gonadorelin has been studied in 61 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for Gonadorelin?
Gonadorelin has a CheckPeptides trust score of 92.5/100 (grade: A+). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- GnRH analogue
- Molecular Weight
- 1182.3 Da
- PubChem
- CID 638793 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 90.0/100
Safety Profile 95.0/100
Evidence Summary
- Clinical Trials
- 61
- Research Papers
- 20
- Trust Score
- 92.5/100
- Grade
- A+